SEARCH

SEARCH BY CITATION

References

  • 1
    Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003; 1: 150414.
  • 2
    Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 18693.
  • 3
    Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 13819.
  • 4
    Jurk K, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005; 31: 38192.
  • 5
    Jackson SP. Arterial thrombosis: insidious, unpredictable and deadly. Nat Med 2011; 17: 142336.
  • 6
    Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 31907.
  • 7
    Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood 2006; 107: 39026.
  • 8
    Kalia N, Auger JM, Atkinson B, Watson SP. Critical role of FcR γ-chain, LAT, PLCγ2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation 2008; 15: 32535.
  • 9
    Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med 2011; 89: 10921.
  • 10
    Kuijpers MJ, Munnix IC, Cosemans JM, van Vlijmen BJ, Reutelingsperger CP, oude Egbrink MG, Heemskerk JW. Key role of platelet procoagulant activity in tissue factor- and collagen-dependent thrombus formation in arterioles and venules in vivo. Differential sensitivity to thrombin inhibition. Microcirculation 2008; 15: 26982.
  • 11
    Brill A, Fuchs TA, Chauhan AK, Yang JJ, de Meyer SF, Köllnberger M, Wakefield TW, Lämmle B, Massberg S, Wagner DD. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117: 14007.
  • 12
    Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest 2005; 115: 335562.
  • 13
    Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010; 11: 288300.
  • 14
    Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 56470.
  • 15
    Zwaal RF, Schroit AJ. Pathophysiological implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 112132.
  • 16
    Munnix IC, Kuijpers MJ, Auger JM, Thomassen CM, Panizzi P, van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation. Regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 2007; 27: 248490.
  • 17
    Berny MA, Munnix IC, Auger JM, Schols SE, Cosemans JM, Panizzi P, Bock PE, Watson SP, McCarty OJ, Heemskerk JW. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. PLoS ONE 2010; 5: e10415.
  • 18
    Jurk K, Lahav J, van Aken H, Brodde MF, Nofer JR, Kehrel BE. Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding. J Thromb Haemost 2011; 9: 227890.
  • 19
    Daubie V, Cauwenberghs S, Senden NHM, Pochet R, Lindhout T, Buurman WA, Heemskerk JW. Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. Biochim Biophys Acta 2006; 1763: 8609.
  • 20
    Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Bernd MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb/IX/V by ADAM family metalloproteinases. J Thromb Haemost 2007; 7: 15307.
  • 21
    Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC, Gardiner EE, Andrews RK. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 2011; 117: 391220.
  • 22
    Ravanat C, Freund M, Mangin P, Azorsa DO, Schwartz C, Moog S, Schuhler S, Dambach J, Cazenave JP, Lanza F. GPV is a marker of in vivo platelet activation: study in a rat thrombosis model. Thromb Haemost 2000; 83: 32733.
  • 23
    Panes O, Matus V, Saez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express tissue factor. Blood 2007; 109: 524250.
  • 24
    Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, Grissom CK, Weyrich AS, Zimmerman GA. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost 2011; 9: 74858.
  • 25
    Kretz CA, Vaezzadeh N, Gross PL. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 2010; 30: 9008.
  • 26
    Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Mast AE. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth. Arterioscler Thromb Vasc Biol 2011; 31: 8216.
  • 27
    Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor. J Biol Chem 2004; 279: 238393.
  • 28
    Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex. Blood 2008; 112: 2795802.
  • 29
    Fager AM, Wood JP, Bouchard BA, Feng P, Tracy PB. Properties of procoagulant platelets: defining and characterization the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol 2010; 30: 24007.
  • 30
    Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of α-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95: 1694702.
  • 31
    Weeterings C, de Groot PG, Adelmeijer J, Lisman T. The glycoprotein Ib–V–IX complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood 2008; 112: 322733.
  • 32
    Lisman T, Adelmeijder J, Cauwenberghs S, van Pampus EC, Heemskerk JW, de Groot PG. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count. J Thromb Haemost 2005; 3: 74251.
  • 33
    Gilbert GE, Novakovic VA, Kaufman RJ, Miao H, Pipe SW. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity. Blood 2012; 120: 192332.
  • 34
    Cosemans JM, Schols SE, Stefanini L, de Witt S, Feijge MA, Hamulyak K, Deckmyn H, Bergmeier W, Heemskerk JW. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 2011; 117: 65160.
  • 35
    London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem 2004; 279: 198549.
  • 36
    London FS, Marcinkiewicz M, Walsh PN. PAR1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium. Biochemistry 2006; 45: 728998.
  • 37
    Walsh PN. Platelet coagulant activities in thrombasthenia. Br J Haematol 1972; 23: 55369.
  • 38
    Renné T, Pozgajova M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 27181.
  • 39
    Van der Meijden PE, Munnix IC, Auger JM, Govers-Riemslag JW, Cosemans JM, Kuijpers MJ, Spronk HM, Watson SP, Renné T, Heemskerk JW. Dual role of collagen in factor XII-dependent thrombus and clot formation. Blood 2009; 114: 88190.
  • 40
    Baglia FA, Shrimpton CN, Emsley J, Kitagawa K, Ruggeri ZM, Lopez JA, Walsh PN. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibα on the activated platelet. J Biol Chem 2004; 279: 493239.
  • 41
    White-Adams TC, Berny MA, Tucker EI, Gertz JM, Gailani D, Urbanus RT, de Groot PG, Gruber A, McCarty OJ. Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol 2009; 29: 16027.
  • 42
    Müller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renné T. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139: 114356.
  • 43
    Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Reinstra CM, Morrissey JH. Polyphosphate exerts differential effects on blood clotting, depending on the polymer size. Blood 2010; 116: 43539.
  • 44
    Choi SH, Smith SA, Morissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 2011; 118: 696370.
  • 45
    Magwenzi SG, Ajjan RA, Standeven KF, Parapia LA, Naseem KM. Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions. J Thromb Haemost 2011; 9: 82033.
  • 46
    Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 1759.
  • 47
    Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, di Paola J. Role of FcRg and factor XIIIa in coated platelet formation. Blood 2005; 106: 414651.
  • 48
    Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, Mast AE. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 2007; 109: 19317.
  • 49
    Boulaftali Y, Ho-Tin-Noe B, Pena A, Loyau S, Venisse L, Francois D, Richard B, Arocas V, Collet JP, Jandrot-Perrus M, Bouton MC. Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation 2011; 12: 132634.
  • 50
    White TC, Berny MA, Tucker EI, Urbanus RT, de Groot PG, Fernandez JA, Griffin JH, Gruber A, McCarty OJ. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J Thromb Haemost 2008; 6: 9951002.
  • 51
    Van‘t Veer C, Butenas S, Golden NJ, Mann KG. Regulation of prothrombinase activity by protein S. Thromb Haemost 1999; 82: 807.
  • 52
    Dayer MR, Ghayour O, Dayer MS. Mechanism of protein Z-mediated inhibition of coagulation factor Xa by Z-protein-dependent inhibitor: a molecular dynamic approach. ISRN Hematol 2012; 2012: in press.
  • 53
    Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102: 114956.
  • 54
    Nesbitt WS, Westein E, Tovar-Lopez FJ, Tolouei E, Mitchell A, Fu J, Carberry J, Fouras A, Jackson SP. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009; 15: 66573.
  • 55
    Kulkarni S, Jackson SP. Platelet factor XIII and calpain negatively regulate integrin αIIbβ3 adhesive function and thrombus growth. J Biol Chem 2004; 279: 30697706.
  • 56
    Heemskerk JW, Kuijpers MJ, Munnix IC, Siljander PR. Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for antithrombotic treatment. Trends Cardiovasc Med 2005; 15: 8692.
  • 57
    Shi J, Pipe JT, Heegaard CW, Gilbert GE. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J Thromb Haemost 2008; 6: 116774.
  • 58
    Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity, physiological significance and mechanisms of exposure. Blood Rev 1991; 5: 14654.
  • 59
    Dale GL. Coated-platelets: an emergic component of the procoagulant response. J Thromb Haemost 2005; 3: 218592.
  • 60
    Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT platelets. Blood 2002; 100: 282731.
  • 61
    Dale GL, Remenyi G, Friese P. Quantitation of microparticles released from coated-platelets. J Thromb Haemost 2005; 3: 20818.
  • 62
    Jobe SM, Wilson KM, Leo L, Raimondi A, Molkentin JD, Lentz SR, diPaola J. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 2008; 111: 125765.
  • 63
    Remenyi G, Szasz R, Frieze P, Dale GL. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler Thromb Vasc Biol 2005; 25: 46771.
  • 64
    Yakimenko AO, Verholomova FY, Kotova YN, Ataullakhanov FI, Panteleev MA. Identification of different proaggregatory abilities of activated platelet subpopulations. Biophys J 2012; 102: 22619.
  • 65
    Schoenwaelder SM, Ono A, Nesbitt WS, Lim J, Jarman K, Jackson SP. Phosphoinositide 3-kinase p110β regulates integrin αIIbβ3 avidity and the cellular transmission of contractile forces. J Biol Chem 2010; 285: 288696.
  • 66
    Brass LF, Zhu L, Stalker TJ. Minding the gaps to promote thrombus growth and stability. J Clin Invest 2005; 115: 338592.
  • 67
    Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Tao Y, Mason KD, O’Reilly LA, Henley KJ, Ono A, Hsiao S, Willcox A, Roberts AW, Huang DCS, Salem HH, Kile BT, Jackson SP. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 6636.
  • 68
    Vogler M, Hamali HA, Sun XM, Bampton ET, Dinsdale D, Snowden RT, Dyer MJS, Goodall AH, Cohen GM. BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis and prevents platelet activation. Blood 2011; 117: 714554.
  • 69
    Kodama T, Takehara T, Hikita H, Shimizu S, Shigekawa M, Li W, Miyagi T, Hosui A, Tatsumi T, Ishida H, Kanto T, Hiramatsu N, Yin XM, Hayashi N. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xl deficiency. Molecular requisites for the mitochondrial pathway to apoptosis in platelets. J Biol Chem 2011; 286: 1390513.
  • 70
    Mason KD, Carpinelli MR, Fletcher JI, Collinga JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, Huang DCS, Kile BT. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 117386.
  • 71
    Curvers J, van Pampus EC, Feijge MA, Rombout-Sestrienkova E, Giesen PL, Heemskerk JW. Decreased responsiveness and development of activation markers of platelets stored in plasma. Transfusion 2004; 44: 4958.
  • 72
    Rand ML, Wang HH, Bang KW, Poon KS, Packham MA, Freedman J. Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence. J Thromb Haemost 2004; 2: 6519.
  • 73
    Albanyan AM, Murphy FM, Rasmussen JT, Heegaard CW, Harrison P. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion 2009; 49: 99107.
  • 74
    Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood 2010; 116: 201118.
  • 75
    Sims J, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome, an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 1704957.
  • 76
    Cauwenberghs S, Feijge MA, Harper AG, Sage SO, Curvers J, Heemskerk JW. Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. FEBS Lett 2006; 580: 531320.
  • 77
    Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2010; 31: 1526.
  • 78
    Vasina E, Heemskerk JW, Weber C, Koenen RR. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets 2010; 9: 34654.
  • 79
    Dörmann D, Clemetson KJ, Kehrel B. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 86: 246978.
  • 80
    Béguin S, Keularts I, al Dieri R, Belluci S, Caen J, Hemker HC. Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a vWF–GPIb-dependent process, defective in Bernard–Soulier syndrome. J Thromb Haemost 2004; 2: 1706.
  • 81
    McNicol A, Sutherland M, Zou R, Drouin J. Defective thrombin-induced calcium changes and aggregation of Bernard–Soulier platelets are not associated with deficient moderate-affinity receptors. Arterioscler Thromb Vasc Biol 1996; 16: 62832.
  • 82
    Ravanat C, Strassel C, Hechler B, Schuhler S, Chicanne G, Payrastre B, Gachet C, Lanza F. A central role of GPIb–IX in the procoagulant function of platelets that is independent of the 45-kDa GPIbα N-terminal extracellular domain. Blood 2010; 116: 115764.
  • 83
    Ramakrishnan V, Reeves PS, DeGuzman F, Deshpande U, Ministri Madrid K, DuBridge RB, Phillips DR. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 1999; 96: 1333641.
  • 84
    Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99: 1293304.
  • 85
    Heemskerk JW, Feijge MA, Henneman L, Rosing J, Hemker HC. The Ca2+-mobilizing potency of α-thrombin and thrombin-receptor-activating peptide on human platelets. Concentration and time effects of thrombin-induced Ca2+ signaling. Eur J Biochem 1997; 249: 54755.
  • 86
    Andersen H, Greenberg DL, Fujikawa K, Xu WF, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 1999; 96: 1118993.
  • 87
    Keuren JF, Wielders SJ, Ulrichts H, Hackeng T, Deckmyn H, Heemskerk JW, Bevers E, Lindhout T. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol 2005; 25: 1499505.
  • 88
    Harper MT, Poole AW. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets. J Thromb Haemost 2011; 9: 1599607.
  • 89
    Dorsam RT, Tuluc M, Kunapuli SP. Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets. J Thromb Haemost 2004; 2: 80412.
  • 90
    Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407: 25864.
  • 91
    Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis. A mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007; 27: 151120.
  • 92
    Trivedi V, Boire A, Tchernychev B, Kaneider NC, Leger AJ, O’Callaghan K, Covic L, Kuliopulos A. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic site. Cell 2009; 137: 33243.
  • 93
    Quinton TM, Kim S, Derian CK, Jin J, Kunapuli SP. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4. J Biol Chem 2004; 279: 184349.
  • 94
    Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 681923.
  • 95
    Lecut C, Schoolmeester A, Kuijpers MJ, Broers JLV, van Zandvoort MA, Vanhoorelbeke K, Deckmyn H, Jandrot-Perrus M, Heemskerk JW. Principal role of glycoprotein VI in α2β1 and αIIbβ3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol 2004; 24: 172733.
  • 96
    Vanschoonbeek K, Feijge MA, van Kampen RJW, Kenis H, Hemker HC, Giesen PL, Heemskerk JW. Initiating and potentiating roles of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2004; 2: 47684.
  • 97
    Léon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, Spannagl M, Gachet C, Engelmann B. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004; 103: 594600.
  • 98
    van der Meijden PE, Schoenwaelder SM, Cosemans JM, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Dual P2Y12 receptor signaling in thrombin-stimulated platelets: involvement of phosphoinositide 3-kinase β but not γ isoforms in Ca2+ mobilization and procoagulant activity. FEBS J 2008; 275: 37185.
  • 99
    van der Meijden PE, Feijge MA, Giesen PL, Huijberts M, van Raak EP, Heemskerk JW. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation: a study with healthy subjects and patients at thrombotic risk. Thromb Haemost 2005; 93: 112837.
  • 100
    Frelinger AL, Jakubowski JA, Li Y, Barnard MR, Linden MD, Rarnow I, Fox ML, Sugidachi A, Winters KJ, Furman MI, Michelson AD. The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities. J Thromb Haemost 2008; 6: 35965.
  • 101
    Judge HM, Buckland RJ, Sugidachi A, Jakubowski JA, Storey RF. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory reactions. Platelets 2008; 19: 12533.
  • 102
    van der Meijden PE, Swieringa S, Feijge MA, Gilio K, Hamulyák K, Heemskerk JW. Integrin αIIbβ3 outside-in signaling causes platelet procoagulant activity and thrombin generation. Cell Mol Life Sci 2012; 69: 348192.
  • 103
    Ilveskero S, Lassila R. Abciximab inhibits procoagulant activity but not the release reaction upon collagen- or clot-adherent platelets. J Thromb Haemost 2003; 1: 80513.
  • 104
    Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM. Differential effects of various anti-GPIIb/IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost 2003; 1: 202230.
  • 105
    Lhermusier T, van Rottem J, Garcia C, Xuereb JM, Ragab A, Martin V, Gratacap MP, Sie P, Payrastre B. The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin–PF4 complex directed antibodies. J Thromb Haemost 2011; 8: 206776.
  • 106
    Siljander P, Farndale RW, Feijge MA, Comfurius P, Kos S, Bevers EM, Heemskerk JW. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol 2001; 21: 61827.
  • 107
    Munnix IC, Strehl A, Kuijpers MJ, Auger JM, van der Meijden PE, van Zandvoort MA, oude Egbrink M, Nieswandt B, Heemskerk JW. The glycoprotein VI–phospholipase Cγ2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo. Arterioscler Thromb Vasc Biol 2005; 25: 26738.
  • 108
    Auger JM, Kuijpers MJ, Senis YA, Watson SP, Heemskerk JW. Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J 2005; 19: 8257.
  • 109
    Elvers M, Pozgai R, Varga-Szabo D, May F, Pleines I, Kuijpers MJ, Heemskerk JW, Nieswandt B. Platelet hyperactivity and a prothrombotic phenotype in mice with a gain-of-function mutation in phospholipase Cγ2. J Thromb Haemost 2010; 8: 135363.
  • 110
    Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 2004; 103: 133341.
  • 111
    Heemskerk JW, Vuist WM, Feijge MA, Reutelingsperger CP, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine and procoagulant activity of adherent platelets. Evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 1997; 90: 261525.
  • 112
    Thomas DH, Getz TM, Newman TN, Dangelmaier CA, Carpino N, Kunapuli SP, Tsygankov AY, Daniel JL. A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets. Blood 2010; 116: 25708.
  • 113
    Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 42936.
  • 114
    Séverin S, Pollitt AY, Navarro-Nunez L, Nash CA, Mourao-Sa D, Eble JA, Senis YA, Watson SP. Syk-dependent phosphorylation of CLEC-2. A novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J Biol Chem 2011; 286: 410716.
  • 115
    Nergiz-Unal R, Lamers MM, van Kruchten R, Luiken JJ, Cosemans JM, Glatz JF, Kuijpers MJ, Heemskerk JW. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low density lipoprotein. J Thromb Haemost 2011; 9: 183546.
  • 116
    White-Adams TC, Berny MA, Patel IA, Tucker EI, Gailani D, Gruber A, McCarty OJ. Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner. J Thromb Haemost 2010; 8: 1295301.
  • 117
    Gilio K, Munnix IC, Mangin P, Cosemans JM, Feijge MA, van der Meijden PE, Olieslagers S, Chrzanowska-Wodnicka MB, Lillian R, Schoenwaelder S, Koyasu S, Sage SO, Jackson SP, Heemskerk JW. Non-redundant roles of phosphoinositide 3-kinase isoforms α and β in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem 2009; 285: 3375062.
  • 118
    Smeets EF, Heemskerk JW, Comfurius P, Bevers EM, Zwaal RF. Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993; 70: 10249.
  • 119
    Varga-Szabo D, Braun A, Kleinschnitz C, Bender M, Pleines I, Pham M, Renné T, Stoll G, Nieswandt B. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 2008; 205: 158391.
  • 120
    Braun A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bender M, Austinat M, Bösi M, Stoll G, Nieswandt B. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 2009; 113: 205663.
  • 121
    Elvers M, Herrmann A, Seizer P, Münzer P, Beck S, Schönberger T, Borst O, Martin-Romero FJ, Lang F, May AE, Gawaz M. Intracellular cyclophilin A is an important Ca2+ regulator in platelets and critically involved in arterial thrombus formation. Blood 2012; 120: 131726.
  • 122
    Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, van der Meijden PE, Kuijpers MJ, Varga-Szabo D, Heemskerk JW, Nieswandt B. Roles of STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 2010; 285: 2362938.
  • 123
    Bergmeier W, Oh-hora M, McCarl CA, Roden RC, Bray PF, Feske S. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009; 109: 68758.
  • 124
    Harper MT, Poole AW. Store-operated calcium entry and non-capacitative calcium entry have distinct roles in thrombin-induced calcium signaling in human platelets. Cell Calcium 2011; 50: 3518.
  • 125
    Ramanathan G, Gupta S, Thielmann I, Pleines I, Varga-Szabo D, May F, Mannhalter C, Dietrich A, Nieswandt B, Braun A. Defective diacylglycerol-induced Ca2+ entry but normal agonist-induced activation responses in TRPC6-deficient mouse platelets. J Thromb Haemost 2012; 10: 41929.
  • 126
    Hassock SR, Zhu MX, Trost C, Flockerzi V, Authi KS. Expression and role of Trpc proteins in human platelets: evidence that Trpc6 forms the store-independent calcium entry channel. Blood 2002; 100: 280111.
  • 127
    Lopez JJ, Salido GM, Pariente JA, Rosado JA. Interaction of Stim1 with endogenously expressed human canonical Trp1 upon depletion of intracellular Ca2+ stores. J Biol Chem 2006; 281: 2825464.
  • 128
    Varga-Szabo D, Authi KS, Braun A, Bender M, Ambily A, Hassock SR, Gudermann T, Dietrich A, Nieswandt B. Store-operated Ca2+ entry in platelets occurs independently of transient receptor potential (TRP) C1. Pflügers Arch 2008; 457: 37787.
  • 129
    Tomasiak M, Stelmach H, Rusak T, Ciborowski M, Radziwon P. The involvement of Na+/K+-ATPase in the development of platelet procoagulant response. Acta Biochim Pol 2007; 54: 62539.
  • 130
    Bucki R, Pastore JL, Giraud F, Janmey PA, Sulpice JC. Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation. Biochim Biophys Acta 2006; 1761: 195204.
  • 131
    Wolfs JL, Wielders SJ, Comfurius P, Lindhout T, Giddings JC, Zwaal RF, Bevers EM. Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 2006; 108: 22238.
  • 132
    Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009; 89: 37484.
  • 133
    Starkov AA. The molecular identity of the mitochondrial Ca2+ sequestration system. FEBS J 2010; 277: 365263.
  • 134
    Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, Nieswandt B, Heemskerk JW. Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J Biol Chem 2007; 282: 704655.
  • 135
    Konopatskaya O, Gilio K, Harper MT, Zhao Y, Cosemans JM, Karim AZ, Whiteheart SW, Molkentin JD, Verkade P, Watson SP, Heemskerk JW, Poole AW. PKCα regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009; 119: 399407.
  • 136
    Gilio K, Harper MT, Cosemans JM, Konopatskaya O, Munnix IC, Prinzen L, Leitges M, Liu Q, Molkentin JD, Heemskerk JW, Poole AW. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem 2010; 285: 2341019.
  • 137
    Harper MT, Poole AW. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 2010; 8: 45462.
  • 138
    Nagy B, Bhavaraju K, Getz T, Bynagari YS, Kim S, Kunapuli SP. Impaired activation of platelets lacking protein kinase C-θ isoform. Blood 2009; 113: 255767.
  • 139
    Stefanini L, Roden RC, Bergmeier W. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood 2009; 114: 250614.
  • 140
    Ahmad F, Boulaftali Y, Greene TK, Ouelette TD, Poncz M, Feske S, Bergmeier W. Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. J Thromb Haemost 2011; 9: 207786.
  • 141
    Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468: 8348.
  • 142
    Castoldi E, Collins PW, Williamson PL, Bevers EM. Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 2011; 117: 4399400.
  • 143
    Munnix IC, Harmsma M, Giddings JC, Collins PW, Feijge MA, Comfurius P, Heemskerk JW, Bevers EM. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003; 89: 68795.
  • 144
    Yang H, Kim A, David T, Palmer D, Jin T, Tien J, Huang F, Cheng T, Coughlin SR, Jan YN, Jan LY. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 2012; 151: 11122.
  • 145
    Bachelot-Loza C, Badol P, Brohard-Bohn B, Fraiz N, Cano E, Rendu F. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain. Br J Haematol 2006; 133: 41926.
  • 146
    Takizawa H, Nishimora S, Takayama N, Oda A, Nishikii H, Morita Y, Kakinuma S, Yamazaki S, Okamura S, Tamura N, Goto S, Sawaguchi A, Manabe I, Takatsu K, Nakauchi H, Takaki S, Eto K. Lnk regulates integrin αIIbβ3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J Clin Invest 2010; 120: 17990.
  • 147
    Suzuki-Inoue K, Hughes CE, Inoue O, Kaneko M, Cuyun-Lira O, Takafuta T, Watson SP, Ozaki Y. Involvement of Src kinases and PLCγ2 in clot retraction. Thromb Res 2007; 120: 2518.
  • 148
    Randriamboavonjy V, Isaak J, Fromel T, Viollet B, Fisslthaler B, Preissner KT, Fleming I. AMPK alpha2 subunit is involved in platelet signaling, clot retraction and thrombus stability. Blood 2010; 116: 213440.
  • 149
    Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP. Deletion of the p110β isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 2010; 115: 200813.
  • 150
    Ono A, Westein E, Hsiao S, Nesbitt WS, Hamilton JR, Schoenwaelder SM, Jackson SP. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 2008; 112: 909.
  • 151
    Kasahara K, Souri M, Kaneda M, Miki T, Yamamoto N, Ichinose A. Impaired clot retraction in factor XIII A subunit-deficient mice. Blood 2010; 115: 12779.
  • 152
    Schoenwaelder SM, Yuan Y, Cooray P, Salem HH, Jackson SP. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin αIIbβ3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J Biol Chem 1997; 272: 1694702.
  • 153
    Verhallen PF, Bevers EM, Comfurius P, Zwaal RF. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry? Biochim Biophys Acta 1987; 903: 20617.
  • 154
    Béguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet-rich plasma. Thromb Haemost 1989; 61: 259.